lipids

01 Jun 2021

Merck accelerates development of synthetic cholesterol to meet COVID-19 vaccine demand

By Staff Writer

To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, Merck has launched a new, high-purity synthetic cholesterol product, nine months ahead of schedule. “Tapping into two decades’ experience of developing and manufacturing high-quality lipids, we designed a proprietary process to bring our new SAFC synthetic cholesterol product to market...

15 Feb 2021

Evonik increases supply of critical lipids for the Pfizer-BioNTech COVID-19 vaccine

By Staff Writer

Evonik is strengthening its strategic partnership with BioNTech in order to establish additional lipid production in Germany for use with mRNA-based COVID-19 vaccines. Commercial lipid quantities are to be produced at Evonik’s Hanau and Dossenheim sites in Germany as early as the second half of 2021 as part of a strategic partnership with vaccine manufacturer...